Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),

PARSIPPANY, N.J. and TEL AVIV, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S

https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-wi

TEVA's latest bid for BioXcel assets could expand its neuroscience portfolio with Igalmi and a poten

BioXcel Chapter 11 sends BTAI shares sharply lower as Teva becomes the stalking horse bidder for IGA

BXCL501, a novel dexmedetomidine sublingual film, is under FDA review for potential at-home (outpati

Neurocrine's strong Ingrezza growth, Crenessity momentum and expanding pipeline make it the stronger

Teva's ecopipam secures FDA priority review for pediatric Tourette syndrome, potentially bringing th

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are up during Thursday's premarket session as the c

Aurinia Pharmaceuticals shares rise after settling patent litigation with Teva, which can launch gen

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) today announced that it and its subsidiary, Aurinia Pharm

EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Settles Patent Litigation with Teva.

Teva's stock gains reflect stronger branded drug growth, a strengthening pipeline and improving fina

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),

PARSIPPANY, N.J. and TEL AVIV, Israel, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S

Health insurer Humana has ‌agreed not to refer to drugmaker Teva as an Israeli company at an upcomin

Barclays analyst Glen Santangelo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweigh

Cetera Investment Advisers grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) by

Assenagon Asset Management S.A. lifted its holdings in Teva Pharmaceutical Industries Ltd. (NYSE: TE

Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus P

Teva Pharmaceuticals has asked a U.S. judge to ​prevent insurer Humana from telling jurors it is an

Teva Pharmaceutical Industries Limited is executing a successful turnaround, driven by its "Pivot to

Teva Pharmaceutical is undergoing a transformation, shifting its revenue mix toward specialty and in

Teva posted its Q2 results this week, reporting an earnings miss even though sales beat expectations

Avidity Partners Management LP increased its holdings in shares of Teva Pharmaceutical Industries Lt

Axiom Investment Management LLC purchased a new position in Teva Pharmaceutical Industries Ltd. (NYS

TEVA misses Q2 earnings estimates as Emalex acquisition costs weigh on profits, while innovative dru

Teva Pharmaceutical Industries NYSE: TEVA reported second-quarter 2026 revenue of approximately $4.1

Teva Pharmaceutical Industries Limited (TEVA) Q2 2026 Earnings Call Transcript

Teva revenue tops estimates despite an earnings miss. The company raises 2026 sales guidance and hig

Teva Pharmaceutical Indus (NYSE:TEVA) lowers FY2026 Adj EPS guidance from $2.57-$2.77 to $1.91-$2.11

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.02 per share which missed th

Piper Sandler analyst David Amsellem maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overw

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE:AN

Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to O

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE: TEVA) and Samsung Bioepis Co., Ltd. today ann

Bill Ackman is bullish on Israel. Here's why he thinks investors should watch the region.

Teva will advance TEV-'408 into a Phase 2b vitiligo study after Phase 1b data showed skin pigmen

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to advance its TEV-’

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

New analysis from the IMPACT-TD Registry demonstrates that treatment with AUSTEDO and AUSTEDO XR led

New real-world survey data reveal the daily impact of Huntington's disease (HD) chorea, with ove

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of AHZANTIVE (a

The olanzapine long-acting injectable (TEV-'749) is designed to deliver the efficacy of olanzapi

The IMPACT-TD findings revealed:A majority of participants, regardless of age, reported a moderate t

Barclays analyst Glen Santangelo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweigh

JP Morgan analyst Chris Schott maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight